KCNE2 was previously identified to be downregulated in gastric cancer and the force expression of KCNE2 could inhibit cancer cell proliferation and cell cycle progression (Abbott & Roepke, 2016; Yanglin et al., 2007). This evidence concerns the gene KCNE2 and cancer.